Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BAQSIMI 3 MG

GLUCAGON : 3 MG · DIN 02492415 · AMPHASTAR PHARMACEUTICALS, INC.

Health Canada status: MARKETED

BAQSIMI 3 MG POWDER - DIN 02492415
BAQSIMI — DIN 02492415. Product photograph held by Nexara Health.

What is BAQSIMI?

BAQSIMI 3 MG contains GLUCAGON : 3 MG. It is listed in the Health Canada Drug Product Database under DIN 02492415, held by AMPHASTAR PHARMACEUTICALS, INC., supplied as POWDER for NASAL administration. Health Canada currently lists it as marketed, status dated 23-Sep-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is BAQSIMI used for?

Treatment of severe hypoglycemic reactions in insulin-treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrates.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02492415
Brand nameBAQSIMI
Generic / active ingredientGLUCAGON : 3 MG
ManufacturerAMPHASTAR PHARMACEUTICALS, INC.
Strength3 MG
Dosage formPOWDER
Route of administrationNASAL
ScheduleEthical
ATC codeH04AA01 GLUCAGON
AHFS class68:22.12
BiosimilarNo
Health Canada statusMARKETED
Status date23-Sep-2024
Original market date2019-11-20 00:00:00

How is it administered?

Recommended dose: 3 mg given intranasally. Insert tip into one nostril and press plunger until green line is gone. Call for medical help immediately. Give oral carbs when patient responds.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Store in the shrink wrapped tube at temperatures up to 30ºC (86ºF). Keep in tube until ready to use to protect from moisture.

How is it supplied?

Single-pack: 1 shrink wrapped tube with single-use device. Two-pack: 2 shrink wrapped tubes with single-use devices.

Contraindications

Known hypersensitivity to glucagon or ingredients; Pheochromocytoma; Insulinoma.

Warnings and precautions

Only for use when impaired consciousness precludes oral carbs. If no response in 15 min, give IV glucose. May cause tachycardia/hypertension. Less effective with alcohol or low liver glycogen.

What can be used instead?

Other Canadian products sharing ATC code H04AA01 GLUCAGON. 1 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
GLUCAGEN1 MGKIT ; POWDER FOR SOLUTIONNOVO NORDISK CANADA INCCANCELLED POST MARKETDIN 02333619
GLUCAGEN HYPOKIT1 MGKIT ; POWDER FOR SOLUTIONNOVO NORDISK CANADA INCCANCELLED POST MARKETDIN 02333627
GLUCAGON1 MGPOWDER FOR SOLUTION ; KITELI LILLY CANADA INCCANCELLED POST MARKETDIN 02243297
GLUCAGON AMPOULE 666 1MG1 MGPOWDER FOR SOLUTIONELI LILLY AND COMPANY LIMITEDCANCELLED POST MARKETDIN 00015377

Who else supplies GLUCAGON worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. GLUCAGON appears in 27 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for BAQSIMI

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for BAQSIMI

Health Canada Drug Product Database (DPD), DIN 02492415. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.